Enlivex Ltd.
corporate_fare Company Profile
Enlivex Ltd. (NASDAQ:ENLV) is a publicly traded company in the Life Sciences sector. Wiseek monitors ENLV SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- Enlivex Secures $400M Private Placement at a Premium, Plus an Option for Another $400M
- $400M Private Placement at 52-Week Low Threatens Massive Dilution
- Enlivex Reports $1.1B RAIN Token Treasury, NAV Per Share at $66.16
- Enlivex's Allocetra™ Lands FDA RMAT Designation for Knee Osteoarthritis, Paving the Way for Expedited Review
- Enlivex Announces 1-for-15 Reverse Split to Avoid Nasdaq Delisting
Financial Snapshot
Dilution Risk
Low riskFiling-implied dilution signals for ENLV, detected from its recent SEC filings · based on capital-structure filings through 2026-05-01.
Resale Registration Filed · Shares from Convertible Note
⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →
Insider Transactions
ENLV files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.